<DOC>
	<DOCNO>NCT01131780</DOCNO>
	<brief_summary>The purpose study assess bioequivalence Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg fasting condition .</brief_summary>
	<brief_title>Bioequivalency Study Ibuprofen 200 mg Pseudoephedrine HCL 30 mg Tablets Dr. Reddy 's Under Fasting Conditions</brief_title>
	<detailed_description>This study assess bioequivalence Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Dr. Reddy 's AdvilÂ® Cold Sinus Caplets Wyeth Consumer Healthcare healthy human adult subject single oral administration fast condition washout period 7 day .</detailed_description>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Healthy human subject 1850 year age ( inclusive ) , weigh per standard height weight chart Life Insurance Corporation India ( II Underweight Overweight Min . &amp; Max . Chart ) Subjects evidence underlie disease screen medical history whose physical examination perform within 21 day commencement study . Subjects whose screen laboratory value within normal limit consider physician/Principal Investigator clinical significance . Informed consent give write form accord section 10.3 protocol . Female Subjects : 1. child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . 2. postmenopausal least 1 year . 3. surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform subject . 1 . History presence significant : Cardiovascular , pulmonary , hepatic , renal hematological ; gastrointestinal , endocrine , immunologic , dermatologic , musculoskeletal , neurological psychiatric disease . Alcohol dependence , alcohol abuse drug abuse within past one year . Moderate heavy smoking ( &gt; 10 cigarettes/day ) assumption tobacco product . History difficulty swallow . Clinically significant illness within 4 week start study Asthma , urticaria allergic type reaction take medication . 2 . Subjects , completion study , would donate excess : 500ml blood 14 day , 500 800 l blood 14 day ( unless approve Principal Investigator ) 1000 ml blood 90 day 1250 ml blood 120 day 1500 ml blood 180 day 2000 ml blood 270 day 2500 ml blood 1 year 3 . Participation another clinical trial within precede 28 day study start . 4 . Subjects : Systolic blood pressure le 90 mm Hg 150 mm Hg Diastolic blood pressure le 60 Hg 95 mm Hg . Minor deviation ( 13 mm Hg ) checkin may acceptable discretion physician/investigator Pulse rate 50/min . 105/min . 5 . Female volunteer demonstrate positive pregnancy screen currently breastfeed .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Crossover</keyword>
	<keyword>Ibuprofen Pseudoephedrine</keyword>
</DOC>